Licensed in Pennsylvania · PA

GLP-1 weight loss telehealth in Pennsylvania

FDA-approved brand-name Wegovy®, Zepbound®, and Foundayo™ prescribed by physicians licensed in Pennsylvania. $29/mo membership — the lowest fee in GLP-1 telehealth. No contracts.

Last clinically reviewed: May 14, 2026 by the Imbue Health Medical Team

How Pennsylvania licensure works on Imbue

Imbue Health prescribes to eligible adults across Pennsylvania — Philadelphia, Pittsburgh, and every borough between — under licensure from the Pennsylvania State Board of Medicine.

Every Pennsylvania prescription Imbue writes goes through a U.S.-licensed, board-certified physician. Medications ship directly from the manufacturer's pharmacy program — NovoCare (Novo Nordisk) for Wegovy® and Oral Wegovy®, LillyDirect (Eli Lilly) for Foundayo™ and Zepbound®. We never use compounding pharmacies.

Major Pennsylvania metros served include Philadelphia, Pittsburgh, Allentown, Erie, Harrisburg — but we prescribe statewide, not just in major cities.

Eligibility for GLP-1 medication in Pennsylvania

  • Adults 18 and older residing in Pennsylvania.
  • BMI ≥30, or BMI ≥25 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease).
  • No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
  • Able to receive shipments from NovoCare and LillyDirect at a Pennsylvania address.
Lowest in industry · $29/mo

Start brand-name GLP-1 in Pennsylvania at $178/mo

$29/mo Imbue Health membership + brand-name medication shipped directly from NovoCare or LillyDirect to your Pennsylvania address. No contracts.